following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like .
1243 Used Today
884 Used Today
318 Used Today
99 Used Today
38 Used Today
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like .
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� . .